Search

everythinglearnresearchcommunity

for

Search:↓

The study found no significant link between Helicobacter pylori infection and polycystic ovary syndrome in young females.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Platelet-rich plasma therapy shows promise in treating hair loss caused by androgenic alopecia.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.

A rare ovarian tumor caused high testosterone and excess hair in a woman, which was resolved after tumor removal.

A 21-year-old male with a rare genetic disorder experienced sudden hair loss and high DHEAS levels, likely due to a condition similar to PCOS, usually seen in women.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.